Zinc-α2-glycoprotein as a marker of fat catabolism in humans

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 3, 2013, Pages 267-271

  Cabassi, Aderville ^a   Tedeschi, Stefano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

adipose tissue; cachexia; fat metabolism; zinc a2 glycoprotein

Indexed keywords

BIOLOGICAL MARKER; CYCLIC AMP; FATTY ACID; GLYCOPROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOSE TISSUE; BODY WEIGHT; CACHEXIA; CATABOLISM; FAT CATABOLISM; FAT MASS; HUMAN; LIPID METABOLISM; LIPOLYSIS; NONHUMAN; PROTEIN FUNCTION; REVIEW; WEIGHT REDUCTION;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ADIPOSITY; AUTOCRINE COMMUNICATION; BIOLOGICAL MARKERS; BODY WEIGHT; CACHEXIA; CHRONIC DISEASE; FATTY ACIDS, NONESTERIFIED; HEART DISEASES; HUMANS; ION CHANNELS; KIDNEY DISEASES; LIPID METABOLISM; LIPOLYSIS; MITOCHONDRIAL PROTEINS; NEOPLASMS; PARACRINE COMMUNICATION; SEMINAL PLASMA PROTEINS;

EID: 84876410460     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835f816c     Document Type: Review

References (20)

1. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr 2008; 27:793-799.
2. von Haehling S, Anker SD. Cachexia as major underestimated unmet medical need: facts and numbers. Int J Cardiol 2012; 161:121-123.
3. Argilés JM, López-Soriano FJ, Toledo M, et al. The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle 2011; 2:87-93.
4. Mracek T, Stephens NA, Gao D, et al. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 2011; 104:441-447.
5. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009; 48:275-297.
6. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89:381-410.
7. Agustsson T, Ryden M, Hoffstedt J, et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res 2007; 67:5531-5537.
8. Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev 2011; 32:550-570.
9. Agustsson T, Wikrantz P, Rydén M, et al. Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia. Nutrition 2012; 28:851-855.
10. Hassan MI, Waheed A, Yadav S, et al. Zinc alpha 2-glycoprotein: a multi-disciplinary protein. Mol Cancer Res 2008; 6:892-906.
11. Tedeschi S, Pilotti E, Parenti E, et al. Serum adipokine zinc a2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers. Metabolism 2012; 61:37-42.
12. Philipp A, Kralisch S, Bachmann A, et al. Serum levels of the adipokine zinc-a2-glycoprotein are increased in chronic hemodialysis. Metabolism 2011; 60:669-672.
13. Russell ST, Tisdale MJ. Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein. Endocrinology 2010; 151:4696-4704.
14. Russell ST, Tisdale MJ. Studies on the antiobesity activity of zinc-a2-glyco-protein in the rat. Int J Obes (Lond) 2011; 35:658-665.
15. Russell ST, Tisdale MJ. Role of b-adrenergic receptors in the antiobesity and antidiabetic effects of zinc-a2-glycoprotien (ZAG). Biochim Biophys Acta 2012; 1821:590-599.
16. Tisdale MJ. Zinc-alpha2-glycoprotein in cachexia and obesity. Curr Opin Support Palliat Care 2009; 3:288-293.
17. Rydén M, Agustsson T, Andersson J, et al. Adipose zinc-a2-glycoprotein is a catabolic marker in cancer and noncancerous states. J Intern Med 2012;271:414-420.
18. Cao DX, Wu GH, Yang ZA, et al. Role of beta1-adrenoceptor in increased lipolysis in cancer cachexia. Cancer Sci 2010; 101:1639-1645.
19. Leal VO, Lobo JC, Stockler-Pinto MB, et al. Is zinc-a2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis? Clin Chim Acta 2012; 413:616-619.
20. Ceperuelo-Mallafré V, Escoté X, Viladés C, et al. Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs. HIV Med 2012; 13:297-303.